Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/ALKS-5461> ?p ?o }
- ALKS-5461 abstract "ALKS-5461 is a combination drug formulation of buprenorphine and samidorphan which is under development by Alkermes as an adjunct to antidepressant therapy in treatment-resistant depression (TRD). It is also under development by Alkermes as a treatment for cocaine dependence, which is being funded by a grant from the National Institute on Drug Abuse (NIDA).".
- ALKS-5461 atcPrefix "none".
- ALKS-5461 thumbnail Buprenorphine_and_samidorphan.svg?width=300.
- ALKS-5461 wikiPageExternalLink 800034331.
- ALKS-5461 wikiPageExternalLink pipeline.
- ALKS-5461 wikiPageID "43221236".
- ALKS-5461 wikiPageLength "24336".
- ALKS-5461 wikiPageOutDegree "98".
- ALKS-5461 wikiPageRevisionID "679115406".
- ALKS-5461 wikiPageWikiLink Addiction.
- ALKS-5461 wikiPageWikiLink Adjuvant_therapy.
- ALKS-5461 wikiPageWikiLink Adverse_effect.
- ALKS-5461 wikiPageWikiLink Affinity_(biochemistry).
- ALKS-5461 wikiPageWikiLink Alkermes_(company).
- ALKS-5461 wikiPageWikiLink Analgesic.
- ALKS-5461 wikiPageWikiLink Anhedonia.
- ALKS-5461 wikiPageWikiLink Antidepressant.
- ALKS-5461 wikiPageWikiLink Anxiety.
- ALKS-5461 wikiPageWikiLink Anxiety_disorder.
- ALKS-5461 wikiPageWikiLink Behavior.
- ALKS-5461 wikiPageWikiLink Behavioural_despair_test.
- ALKS-5461 wikiPageWikiLink Blind_experiment.
- ALKS-5461 wikiPageWikiLink Buprenorphine.
- ALKS-5461 wikiPageWikiLink CERC-501.
- ALKS-5461 wikiPageWikiLink Category:Antidepressants.
- ALKS-5461 wikiPageWikiLink Category:Combination_drugs.
- ALKS-5461 wikiPageWikiLink Category:Drug_rehabilitation.
- ALKS-5461 wikiPageWikiLink Category:Kappa_antagonists.
- ALKS-5461 wikiPageWikiLink Category:Morphinans.
- ALKS-5461 wikiPageWikiLink Category:Semisynthetic_opioids.
- ALKS-5461 wikiPageWikiLink Category:Synthetic_opioids.
- ALKS-5461 wikiPageWikiLink Chronic_stress.
- ALKS-5461 wikiPageWikiLink Clinical_trial.
- ALKS-5461 wikiPageWikiLink Cocaine.
- ALKS-5461 wikiPageWikiLink Combination_drug.
- ALKS-5461 wikiPageWikiLink Conditioned_place_preference.
- ALKS-5461 wikiPageWikiLink Constipation.
- ALKS-5461 wikiPageWikiLink Contraindication.
- ALKS-5461 wikiPageWikiLink Cure.
- ALKS-5461 wikiPageWikiLink Depression_(mood).
- ALKS-5461 wikiPageWikiLink Depressive_disorder.
- ALKS-5461 wikiPageWikiLink Dizziness.
- ALKS-5461 wikiPageWikiLink Double-blind.
- ALKS-5461 wikiPageWikiLink Drug_addiction.
- ALKS-5461 wikiPageWikiLink Drug_dependence.
- ALKS-5461 wikiPageWikiLink Drug_interaction.
- ALKS-5461 wikiPageWikiLink Dry_mouth.
- ALKS-5461 wikiPageWikiLink Dynorphin.
- ALKS-5461 wikiPageWikiLink Dysphoria.
- ALKS-5461 wikiPageWikiLink Efficacy.
- ALKS-5461 wikiPageWikiLink Electroconvulsive_therapy.
- ALKS-5461 wikiPageWikiLink Endogenous.
- ALKS-5461 wikiPageWikiLink Endogeny_(biology).
- ALKS-5461 wikiPageWikiLink Endorphin.
- ALKS-5461 wikiPageWikiLink Endorphins.
- ALKS-5461 wikiPageWikiLink Euphoria.
- ALKS-5461 wikiPageWikiLink FDA_Fast_Track_Development_Program.
- ALKS-5461 wikiPageWikiLink Fast_Track_Designation.
- ALKS-5461 wikiPageWikiLink Food_and_Drug_Administration.
- ALKS-5461 wikiPageWikiLink Forced_swimming_test.
- ALKS-5461 wikiPageWikiLink Gene.
- ALKS-5461 wikiPageWikiLink Headache.
- ALKS-5461 wikiPageWikiLink Hypothalamic-pituitary-adrenal_axis.
- ALKS-5461 wikiPageWikiLink Hypothalamic–pituitary–adrenal_axis.
- ALKS-5461 wikiPageWikiLink JDTic.
- ALKS-5461 wikiPageWikiLink Kappa-opioid_receptor.
- ALKS-5461 wikiPageWikiLink Knockout_mouse.
- ALKS-5461 wikiPageWikiLink LY-2940094.
- ALKS-5461 wikiPageWikiLink Ligand.
- ALKS-5461 wikiPageWikiLink Ligand_(biochemistry).
- ALKS-5461 wikiPageWikiLink Major_depressive_disorder.
- ALKS-5461 wikiPageWikiLink Mental_disorder.
- ALKS-5461 wikiPageWikiLink Montgomery–Åsberg_Depression_Rating_Scale.
- ALKS-5461 wikiPageWikiLink Morphine.
- ALKS-5461 wikiPageWikiLink Mu-opioid_receptor.
- ALKS-5461 wikiPageWikiLink NSI-189.
- ALKS-5461 wikiPageWikiLink National_Institute_on_Drug_Abuse.
- ALKS-5461 wikiPageWikiLink Nausea.
- ALKS-5461 wikiPageWikiLink Neuroplasticity.
- ALKS-5461 wikiPageWikiLink New_Drug_Application.
- ALKS-5461 wikiPageWikiLink New_drug_application_(FDA).
- ALKS-5461 wikiPageWikiLink Onset_of_action.
- ALKS-5461 wikiPageWikiLink Opioid_antagonist.
- ALKS-5461 wikiPageWikiLink Opioid_modulator.
- ALKS-5461 wikiPageWikiLink Opioid_peptide.
- ALKS-5461 wikiPageWikiLink PF-4455242.
- ALKS-5461 wikiPageWikiLink Pain_management.
- ALKS-5461 wikiPageWikiLink Partial_agonist.
- ALKS-5461 wikiPageWikiLink Pharmaceutical_formulation.
- ALKS-5461 wikiPageWikiLink Pharmacokinetic.
- ALKS-5461 wikiPageWikiLink Pharmacokinetics.
- ALKS-5461 wikiPageWikiLink Phase_1.
- ALKS-5461 wikiPageWikiLink Phase_I.
- ALKS-5461 wikiPageWikiLink Phase_III.
- ALKS-5461 wikiPageWikiLink Phases_of_clinical_research.
- ALKS-5461 wikiPageWikiLink Physiology.
- ALKS-5461 wikiPageWikiLink Placebo-controlled.
- ALKS-5461 wikiPageWikiLink Placebo-controlled_study.
- ALKS-5461 wikiPageWikiLink Precursor_(chemistry).
- ALKS-5461 wikiPageWikiLink Prodynorphin.